Lauren Powell

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)

Karissa Johnston, Linda Harris, Lauren Powell et al. · The Journal of Headache and Pain · 2022 · 41 citations · Full text

Real-World experience of interictal burden and treatment in migraine: a qualitative interview study

Siu Hing Lo, Katy Gallop, Timothy R. Smith et al. · The Journal of Headache and Pain · 2022 · 34 citations · Full text

Measuring interictal burden among people affected by migraine: a descriptive survey study

Lena Hubig, Timothy R. Smith, Emma Williams et al. · The Journal of Headache and Pain · 2022 · 30 citations · Full text

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant

Karissa Johnston, Gilbert L’Italien, Evan Popoff et al. · Advances in Therapy · 2021 · 22 citations · Full text

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine

Evan Popoff, Karissa Johnston, Robert Croop et al. · Headache The Journal of Head and Face Pain · 2021 · 17 citations · Full text